Clinical trial · Observational
Impact of the Experience of Anaesthetists in Changing Ventilation Strategies During Panendoscopy on the Incidence of Intraoperative Hypoxaemia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
High Flow Nasal Oxygen Therapy (HFNO) is a new oxygenation tool that is becoming increasingly widespread in perioperative anaesthesia. The benefits of this oxygenation tool are based on different physiological principles. These include the reduction of dead space by "flushing" the nasopharyngeal cavities, positive airway pressure and the warming and humidification of inspired air. In addition, the high flow rates used ensure that the patient's inspiratory demand is covered, allowing for the delivery of oxygen-enriched and controlled air. It is simple to use, with the only parameters to be set being gas flow and FiO2. The use of HFNO appears to allow a prolongation of apnoea time without desaturation in apneic ventilation. Mainly studied in ENT surgery because of the interest that this oxygenation strategy presents with the absence of recourse to oro-tracheal intubation (OTI), several authors will use it in the framework of micro-laryngoscopy surgery in suspension. However, its use as an oxygenation strategy during panendoscopy has been little explored. Panendoscopy is a common procedure that requires deep and short anesthesia. The main challenge is the sharing of the airway between the anesthesia team and the surgical team. Learning to use this new method or the impact of operator experience has never been explored.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| ENT Tumor | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Proportion of patients with oxygen desaturation
- timeFrame
- during the intervention (max 6hours)from induction of anaesthesia to discharge from the operating theatre
- description
- Proportion of patients with oxygen desaturation (SpO2 \< 90%) for more than 1 minute.
Secondary outcomes (4)
- measure
- Proportion of patients within each of the ventilation modalities used in panendoscopies
- timeFrame
- during the intervention (max 6hours)from induction of anaesthesia to discharge from the operating theatre
- description
- Proportion of patients within each of the ventilation modalities used in panendoscopies Proportion of patients requiring repeat face mask ventilation (at least one reventilation outside the initial denitrogenation)
- measure
- Proportion of patients requiring oro-tracheal intubation
- description
- Proportion of patients intubated during panendoscopy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * major patients receiving panendoscopy Exclusion Criteria: * panendoscopies performed in combination with another invasive procedure that may alter anaesthetic management
References
Publications (0)
Data not yet available